The CRISPR-Cas12a Platform for Accurate Genome Editing, Gene Disruption, and Efficient Transgene Integration in Human Immune Cells-Reference-Cited by-同舟云学术

The CRISPR-Cas12a Platform for Accurate Genome Editing, Gene Disruption, and Efficient Transgene Integration in Human Immune Cells

Published:2023-02-07 Issue:2 Volume:12 Page:375-389
ISSN:2161-5063
Container-title:ACS Synthetic Biology
language:en
Short-container-title:ACS Synth. Biol.

Author:

Mohr Marina¹^ORCID,Damas Nkerorema¹,Gudmand-Høyer Johanne¹,Zeeberg Katrine¹,Jedrzejczyk Dominika¹^ORCID,Vlassis Arsenios¹,Morera-Gómez Martí¹,Pereira-Schoning Sara²,Puš Urška¹,Oliver-Almirall Anna¹,Lyholm Jensen Tanja¹,Baumgartner Roland²,Tate Weinert Brian¹,Gill Ryan T.¹²,Warnecke Tanya²

Affiliation:

1. Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, Kemitorvet 220, 2800 Kongens Lyngby, Denmark

2. Artisan Bio, 363 Centennial Parkway, Suite 310, Louisville, Colorado 80027, United States

Funder

Novo Nordisk Fonden

Publisher

American Chemical Society (ACS)

Subject

Biochemistry, Genetics and Molecular Biology (miscellaneous),Biomedical Engineering,General Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acssynbio.2c00179

Reference48 articles.

1. The promise and challenge of therapeutic genome editing

2. The CRISPR tool kit for genome editing and beyond

3. The new frontier of genome engineering with CRISPR-Cas9

4. Optimization of AsCas12a for combinatorial genetic screens in human cells

5. A more efficient CRISPR-Cas12a variant derived from Lachnospiraceae bacterium MA2020

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficient editing of the CXCR4 locus using Cas9 ribonucleoprotein complexes stabilized with polyglutamic acid;Доклады Российской академии наук. Науки о жизни;2024-07-05

2. Discovery and engineering of AiEvo2, a novel Cas12a nuclease for human gene editing applications;Journal of Biological Chemistry;2024-03

3. The CRISPR Cas patent files, part 2: Is Cpf1/Cas12a a less conflict- prone alternative to Cas9?;Journal of Biotechnology;2024-02

4. CRISPR-Cas12a for Highly Efficient and Marker-Free Targeted Integration in Human Pluripotent Stem Cells;International Journal of Molecular Sciences;2024-01-12

5. Increasing Gene Editing Efficiency via CRISPR/Cas9- or Cas12a-Mediated Knock-In in Primary Human T Cells;Biomedicines;2024-01-06